metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology Prevalence of hepatobiliary manifestations and its relationship with the time of...
Journal Information
Vol. 27. Issue S3.
Abstracts from XVII Mexican Congress of Hepatology
(December 2022)
Share
Share
Download PDF
More article options
Vol. 27. Issue S3.
Abstracts from XVII Mexican Congress of Hepatology
(December 2022)
Open Access
Prevalence of hepatobiliary manifestations and its relationship with the time of evolution of inflammatory bowel disease in patients attended at Centro Médico Nacional 20 de noviembre
Visits
187
LO Rodríguez Muñoz1, IE Severino Ferreras1, JL Hernández Lecona1, JG López Gómez2, M Narváez Méndez1, KG Peña Genao1
1 Gastroenterology Department, National Medical Center 20 de Noviembre, ISSSTE. Mexico City, Mexico
2 Inflammatory Bowel Disease Clinic. National Medical Center 20 de Noviembre, ISSTE. Mexico City, Mexico
This item has received

Under a Creative Commons license
Article information
Abstract
Full Text
Download PDF
Statistics
Figures (1)
Special issue
This article is part of special issue:
Vol. 27. Issue S3

Abstracts from XVII Mexican Congress of Hepatology

More info
Introduction and Objective

This study aimed to describe the prevalence of hepatobiliary manifestations of Inflammatory Bowel Disease.

Materials and Methods

A retrospective, observational, cross-sectional study. Sixty-two patients with UC (UC) and 29 patients with Crohn's disease were included. Medical notes and imagenological studies were reviewed from the first registered consultation in search of known hepatobiliary manifestations (HBM) of Inflammatory Bowel Disease (IBD). Data were analyzed using STATA software version 16.

Results

HBM were found in 35.48% of CUCI and 37.93% of Crohn's. In both IBD it was more common to find only 1 HBM (UC: 19.35%; Crohn: 31.03%), being the 3 most common NAFLD (UC: 36.36%; Crohn: 60%), cholelithiasis (UC: 33.3%; Crohn: 26.66 %) and PSC (SITC: 15.15%, Crohn's: 6.66%). HBM were more frequent in less than <5 years after diagnosis; however, in patients with UC, HBM were found at a longer time of disease´s evolution.

Conclusions

It is essential to monitor liver function in patients with IBD at regular intervals; as well as implement screening strategies with imagenological studies to detect HMB since it must be considered that even in a short evolution time, we must carry out an early screening in search of these MHB.

Funding

The resources used in this study were from the hospital without any additional financing

Declaration of interest

The authors declare no potential conflicts of interest.

Full text is only aviable in PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos